Visual Findings of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Cardiac Sarcoidosis
Objective The purpose of this study was to evaluate the cardiac sarcoidosis (CS) activity according to the classified visual uptake pattern using 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) and assess the uptake pattern based on the free fatty acid (FFA)...
Saved in:
| Published in | Internal Medicine Vol. 53; no. 18; pp. 2041 - 2049 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
The Japanese Society of Internal Medicine
2014
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0918-2918 1349-7235 |
| DOI | 10.2169/internalmedicine.53.2491 |
Cover
| Abstract | Objective The purpose of this study was to evaluate the cardiac sarcoidosis (CS) activity according to the classified visual uptake pattern using 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) and assess the uptake pattern based on the free fatty acid (FFA) levels. Methods Nineteen CS subjects who underwent 18F-FDG PET/CT examinations with heparin loading (HL) were recruited to evaluate their CS activity. The 18F-FDG uptake in the heart was classified into five categories ("none," "diffuse" and "diffuse at base," regarded as stable CS, and "focal" and "focal on diffuse," regarded as de novo or worsening CS). The subject data were compared with the 18F-FDG PET/CT findings in 13 healthy volunteers. The FFA serum levels were assessed in 10 patients with CS and all volunteers. Results The sensitivity and specificity of 18F-FDG PET/CT with HL were 75% (6/8) and 73% (8/11), respectively. The major pattern of cardiac 18F-FDG uptake was "diffuse at base." Ten of the 32 subjects, including the control group, exhibited this pattern. The FFA serum levels before heparin administration were statistically significantly different between the patients with the "none" pattern and those with the "diffuse" and "diffuse at base" patterns. There were no significant correlations between the FFA serum levels after heparin administration and the 18F-FDG uptake patterns. Conclusion "Diffuse at base" is the major 18F-FDG uptake pattern associated with inadequate physiologic 18F-FDG suppression. This pattern should be carefully interpreted when examining the 18F-FDG PET/CT images of CS patients. Additionally, increased FFAs levels associated with HL may not completely suppress the physiologic myocardial FDG uptake. |
|---|---|
| AbstractList | Objective The purpose of this study was to evaluate the cardiac sarcoidosis (CS) activity according to the classified visual uptake pattern using 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) and assess the uptake pattern based on the free fatty acid (FFA) levels. Methods Nineteen CS subjects who underwent 18F-FDG PET/CT examinations with heparin loading (HL) were recruited to evaluate their CS activity. The 18F-FDG uptake in the heart was classified into five categories ("none," "diffuse" and "diffuse at base," regarded as stable CS, and "focal" and "focal on diffuse," regarded as de novo or worsening CS). The subject data were compared with the 18F-FDG PET/CT findings in 13 healthy volunteers. The FFA serum levels were assessed in 10 patients with CS and all volunteers. Results The sensitivity and specificity of 18F-FDG PET/CT with HL were 75% (6/8) and 73% (8/11), respectively. The major pattern of cardiac 18F-FDG uptake was "diffuse at base." Ten of the 32 subjects, including the control group, exhibited this pattern. The FFA serum levels before heparin administration were statistically significantly different between the patients with the "none" pattern and those with the "diffuse" and "diffuse at base" patterns. There were no significant correlations between the FFA serum levels after heparin administration and the 18F-FDG uptake patterns. Conclusion "Diffuse at base" is the major 18F-FDG uptake pattern associated with inadequate physiologic 18F-FDG suppression. This pattern should be carefully interpreted when examining the 18F-FDG PET/CT images of CS patients. Additionally, increased FFAs levels associated with HL may not completely suppress the physiologic myocardial FDG uptake. |
| Author | Okazaki, Osamu Ito, Kimiteru Morooka, Miyako Hiroe, Michiaki Minamimoto, Ryogo Kubota, Kazuo |
| Author_xml | – sequence: 1 fullname: Kubota, Kazuo organization: Department of Nuclear Medicine, National Center for Global Health and Medicine, Japan – sequence: 1 fullname: Minamimoto, Ryogo organization: Department of Nuclear Medicine, National Center for Global Health and Medicine, Japan – sequence: 1 fullname: Morooka, Miyako organization: Department of Nuclear Medicine, National Center for Global Health and Medicine, Japan – sequence: 1 fullname: Ito, Kimiteru organization: Department of Radiology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Japan – sequence: 1 fullname: Okazaki, Osamu organization: Department of Cardiology, National Center for Global Health and Medicine, Japan – sequence: 1 fullname: Hiroe, Michiaki organization: Department of Cardiology, National Center for Global Health and Medicine, Japan |
| BookMark | eNqNkFtLAzEQhYMoWC__IX9gay57y4sgxapQULD4uozZaTuym5QkRfvkX3dLi4j44MvMcDjnYzhn7Nh5h4xxKcZKluaKXMLgoOuxJUsOx4Ueq9zIIzaSOjdZpXRxzEbCyDpTwzhlZzG-CaHryqgR-3yhuIGOT8m15JaR-wWX9TSbdhsffIv-Y7vsNtZH5E8-Ugre8dueYqThmPveLwOsV9urie_Xm4TtD42T40-QCF2K_J3Sik8gtASWP0OwntqBFy_YyQK6iJeHfc7m09v55D6bPd49TG5mmVVCuKyo8lIIKUGUhXzNK10OgjRtZaxGJXRZC2x1rl41GKgGn0RQwqDRxQKV1Ofseo-1wccYcNFYSsNv3qUA1DVSNLs2m99tNoVudm0OgPoXYB2oh7D9T_RxH32LCZb4HYSQyHb4Z1DWu3kgfDvtCkKDTn8B_NKjQw |
| CitedBy_id | crossref_primary_10_1007_s12350_018_01582_y crossref_primary_10_1097_RLU_0000000000001465 crossref_primary_10_1007_s00259_018_4195_9 crossref_primary_10_1536_ihj_17_492 crossref_primary_10_4070_kcj_2021_0104 crossref_primary_10_1016_j_crad_2018_09_015 crossref_primary_10_1016_j_jcmg_2023_05_017 crossref_primary_10_1007_s12350_018_1404_7 crossref_primary_10_1007_s12410_019_9485_5 crossref_primary_10_1007_s12350_017_0962_4 crossref_primary_10_1007_s12350_017_1122_6 crossref_primary_10_1148_radiol_213170 crossref_primary_10_1016_j_clinimag_2024_110248 |
| Cites_doi | 10.1056/NEJM199704243361706 10.1097/RLU.0b013e318266cb25 10.1007/s12149-013-0721-9 10.1093/eurheartj/ehi180 10.1016/j.jcmg.2010.09.015 10.1007/s12350-009-9110-0 10.1378/chest.103.1.253 10.1111/j.1445-5994.2007.01590.x 10.1016/S0002-9149(01)01978-6 10.1007/s00259-011-1832-y 10.1007/s12350-013-9798-8 10.1186/2191-219X-4-1 10.2967/jnumed.107.041574 10.1016/S0002-9149(98)00377-4 10.1016/0735-1097(90)92035-Z 10.1111/j.1749-6632.1976.tb47058.x |
| ContentType | Journal Article |
| Copyright | 2014 by The Japanese Society of Internal Medicine |
| Copyright_xml | – notice: 2014 by The Japanese Society of Internal Medicine |
| DBID | AAYXX CITATION |
| DOI | 10.2169/internalmedicine.53.2491 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1349-7235 |
| EndPage | 2049 |
| ExternalDocumentID | 10_2169_internalmedicine_53_2491 article_internalmedicine_53_18_53_53_2491_article_char_en |
| GroupedDBID | --- .55 29J 2WC 3O- 53G 5GY ACPRK ADBBV ADRAZ AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CS3 DIK DU5 EBS EJD EMOBN F5P HYE JSF JSH M48 OK1 OVT P2P PGMZT RJT RNS RPM RZJ TKC TR2 X7M XSB AAYXX CITATION |
| ID | FETCH-LOGICAL-c200n-57460011a0651b473674619d79c3e203680ed342b3a9a711a1ea209e935fe213 |
| ISSN | 0918-2918 |
| IngestDate | Tue Jul 01 01:39:56 EDT 2025 Thu Apr 24 22:54:42 EDT 2025 Wed Sep 03 06:15:01 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 18 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c200n-57460011a0651b473674619d79c3e203680ed342b3a9a711a1ea209e935fe213 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/internalmedicine/53/18/53_53.2491/_article/-char/en |
| PageCount | 9 |
| ParticipantIDs | crossref_citationtrail_10_2169_internalmedicine_53_2491 crossref_primary_10_2169_internalmedicine_53_2491 jstage_primary_article_internalmedicine_53_18_53_53_2491_article_char_en |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014 |
| PublicationDateYYYYMMDD | 2014-01-01 |
| PublicationDate_xml | – year: 2014 text: 2014 |
| PublicationDecade | 2010 |
| PublicationTitle | Internal Medicine |
| PublicationTitleAlternate | Intern. Med. |
| PublicationYear | 2014 |
| Publisher | The Japanese Society of Internal Medicine |
| Publisher_xml | – name: The Japanese Society of Internal Medicine |
| References | 8. Ohira H, Tsujino I, Yoshinaga K. 18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging 38: 1773-1783, 2011. 20. Gropler RJ, Siegel BA, Lee KJ, et al. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 31: 1749-1756, 1990. 6. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 88: 1006-1010, 2001. 5. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann NY Acad Sci 278: 455-469, 1976. 22. Tamaki N, Yonekura Y, Kawamoto M, et al. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition. J Nucl Med 32: 2152-2157, 1991. 9. Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with 13N-NH3/18F-FDG PET. J Nucl Med 44: 1030-1036, 2003. 10. Ishimaru S, Tsujino I, Takei T, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 26: 1538-1543, 2005. 23. Minamimoto R, Morooka M, Miyata Y, et al. Incidental focal FDG uptake in heart is a lighthouse for considering cardiac screening. Ann Nucl Med 27: 572-580, 2013. 2. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 103: 253-258, 1993. 19. Sugisaki K. Diagnostic Guidelines and Criteria for Sarcoidosis-2006. Nihon Kokyuki Gakkai Zasshi 46: 768-780, 2008 (in Japanese). 17. Morooka M, Moroi M, Uno K, et al. Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis. EJNMMI Res 4: 1, 2014. 21. Inglese E, Leva L, Matheoud R, et al. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT. J Nucl Med 48: 1662-1669, 2007. 11. Langah R, Spicer K, Gebregziabher M, Gordon L. Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol 16: 801-810, 2009. 13. Ishimaru S, Tsujino I, Sakaue S, et al. Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22: 234-235, 2005. 15. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33: 1972-1980, 1992. 1. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 336: 1224-1234, 1997. 3. Habersberger J, Manins V, Taylor AJ. Cardiac sarcoidosis. Intern Med J 38: 270-277, 2008. 14. Tahara N, Tahara A, Nitta Y, et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging 3: 1219-1228, 2010. 4. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58: 1204-1211, 1978. 12. Okumura W, Iwasaki T, Toyama T, et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 45: 1989-1998, 2004. 7. Yazaki Y, Isobe M, Hiramitsu S, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol 82: 537-540, 1998. 16. Ito K, Morooka M, Okazaki O, Minaminoto R, Kubota K, Hiroe M. Efficacy of Heparin Loading During an 18F-FDG PET/CT Examination to Search for Cardiac Sarcoidosis Activity. Clin Nucl Med 38: 128-130, 2013. 18. Gormsen LC, Christensen NL, Bendstrup E, Tolbod LP, Nielsen SS. Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis. J Nucl Cardiol 20: 1108-1115, 2013. 11 22 12 23 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 10 21 |
| References_xml | – reference: 17. Morooka M, Moroi M, Uno K, et al. Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis. EJNMMI Res 4: 1, 2014. – reference: 18. Gormsen LC, Christensen NL, Bendstrup E, Tolbod LP, Nielsen SS. Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis. J Nucl Cardiol 20: 1108-1115, 2013. – reference: 21. Inglese E, Leva L, Matheoud R, et al. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT. J Nucl Med 48: 1662-1669, 2007. – reference: 16. Ito K, Morooka M, Okazaki O, Minaminoto R, Kubota K, Hiroe M. Efficacy of Heparin Loading During an 18F-FDG PET/CT Examination to Search for Cardiac Sarcoidosis Activity. Clin Nucl Med 38: 128-130, 2013. – reference: 20. Gropler RJ, Siegel BA, Lee KJ, et al. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 31: 1749-1756, 1990. – reference: 1. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 336: 1224-1234, 1997. – reference: 2. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 103: 253-258, 1993. – reference: 5. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann NY Acad Sci 278: 455-469, 1976. – reference: 9. Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with 13N-NH3/18F-FDG PET. J Nucl Med 44: 1030-1036, 2003. – reference: 19. Sugisaki K. Diagnostic Guidelines and Criteria for Sarcoidosis-2006. Nihon Kokyuki Gakkai Zasshi 46: 768-780, 2008 (in Japanese). – reference: 14. Tahara N, Tahara A, Nitta Y, et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging 3: 1219-1228, 2010. – reference: 22. Tamaki N, Yonekura Y, Kawamoto M, et al. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition. J Nucl Med 32: 2152-2157, 1991. – reference: 4. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58: 1204-1211, 1978. – reference: 11. Langah R, Spicer K, Gebregziabher M, Gordon L. Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol 16: 801-810, 2009. – reference: 3. Habersberger J, Manins V, Taylor AJ. Cardiac sarcoidosis. Intern Med J 38: 270-277, 2008. – reference: 12. Okumura W, Iwasaki T, Toyama T, et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 45: 1989-1998, 2004. – reference: 13. Ishimaru S, Tsujino I, Sakaue S, et al. Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22: 234-235, 2005. – reference: 8. Ohira H, Tsujino I, Yoshinaga K. 18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging 38: 1773-1783, 2011. – reference: 23. Minamimoto R, Morooka M, Miyata Y, et al. Incidental focal FDG uptake in heart is a lighthouse for considering cardiac screening. Ann Nucl Med 27: 572-580, 2013. – reference: 10. Ishimaru S, Tsujino I, Takei T, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 26: 1538-1543, 2005. – reference: 7. Yazaki Y, Isobe M, Hiramitsu S, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol 82: 537-540, 1998. – reference: 15. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33: 1972-1980, 1992. – reference: 6. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 88: 1006-1010, 2001. – ident: 1 doi: 10.1056/NEJM199704243361706 – ident: 16 doi: 10.1097/RLU.0b013e318266cb25 – ident: 23 doi: 10.1007/s12149-013-0721-9 – ident: 4 – ident: 10 doi: 10.1093/eurheartj/ehi180 – ident: 14 doi: 10.1016/j.jcmg.2010.09.015 – ident: 11 doi: 10.1007/s12350-009-9110-0 – ident: 12 – ident: 2 doi: 10.1378/chest.103.1.253 – ident: 3 doi: 10.1111/j.1445-5994.2007.01590.x – ident: 6 doi: 10.1016/S0002-9149(01)01978-6 – ident: 8 doi: 10.1007/s00259-011-1832-y – ident: 19 – ident: 13 – ident: 15 – ident: 18 doi: 10.1007/s12350-013-9798-8 – ident: 17 doi: 10.1186/2191-219X-4-1 – ident: 21 doi: 10.2967/jnumed.107.041574 – ident: 7 doi: 10.1016/S0002-9149(98)00377-4 – ident: 20 doi: 10.1016/0735-1097(90)92035-Z – ident: 9 – ident: 5 doi: 10.1111/j.1749-6632.1976.tb47058.x – ident: 22 |
| SSID | ssj0038792 |
| Score | 1.9939415 |
| Snippet | Objective The purpose of this study was to evaluate the cardiac sarcoidosis (CS) activity according to the classified visual uptake pattern using... |
| SourceID | crossref jstage |
| SourceType | Enrichment Source Index Database Publisher |
| StartPage | 2041 |
| SubjectTerms | cardiac sarcoidosis free fatty acid heparin loading PET physiologic uptake |
| Title | Visual Findings of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Cardiac Sarcoidosis |
| URI | https://www.jstage.jst.go.jp/article/internalmedicine/53/18/53_53.2491/_article/-char/en |
| Volume | 53 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Internal Medicine, 2014, Vol.53(18), pp.2041-2049 |
| journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1349-7235 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0038792 issn: 0918-2918 databaseCode: DIK dateStart: 19920101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKghAXxFO7vOQDt1W6cey8jmi1VZdVYQ8B7S1KYlcq7caobSTaCz-QP8VMbKdhVcSyl6gdxdPG82U8Hs-DkPeBjCNR-JUXJpHwROkrL5E89bhSIo1KWPHa6vqTT9H4i_h4FV4NBr96UUvNuhxW2715JXeRKtBArpgl-x-S7ZgCAT6DfOEKEobrrWT8dbbC7I_RrE1NaYMyWDLyRotGg15U-sfGRaRfYmzWEiR9BnJFB9lxpq9ttWoskWt6O8geFR0hl6boqs2AO23BVKETudIzCRxXfdPW-hYX3XE9Gq-Znm9aZyzGn_a8Dudt96bjiza9atl0rt55sS1MI-3Pq-K6o0_gefS8MHH-m2KudydQpV7brLZto_s-DJM16tyQDLNArA5WRglzkXpxYMqYOC1tSgo7NCZ9neub0ll2_Yav6b61IWARllad2clwczEM-RC2oGy3HroYgBvLZBe8CNsm5JXf5JSHPEdO98j9AJ1DaKGfXzizgCdx26G7e2ATVoacTv72n_6wlR58g-2CCzVsrZ_sCXlsty30g8HgUzJQ9TPycGI5PSc_DRSpgyLVU7ofitRBkToo0h3oThwQezQ6q6kDIkUgUgtE2gPiC5KNzrLTsWd7e3gVvMG1F8YCTW1WgAnMShHzCAgslXFacYWH44mvJBdByYu0iOE-porAT1XKw6kKGH9JDmpdq0NCJVdg84tYqmklKmywxuOyYomQolShL49I7CYxr2zde2y_ssj_JcgjwrqR303tl1uMGRs5dSOsdtg7giV4tUO7OzHfEtTbqzv8_GvyCN8v4yN8Qw7Wy0a9Bat5Xb5r0fgbOM7O_w |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Visual+Findings+of+18F-Fluorodeoxyglucose+Positron+Emission+Tomography%2FComputed+Tomography+in+Patients+with+Cardiac+Sarcoidosis&rft.jtitle=Internal+medicine+%28Tokyo%2C+1992%29&rft.au=Ito%2C+Kimiteru&rft.au=Okazaki%2C+Osamu&rft.au=Morooka%2C+Miyako&rft.au=Kubota%2C+Kazuo&rft.date=2014&rft.issn=0918-2918&rft.eissn=1349-7235&rft.volume=53&rft.issue=18&rft.spage=2041&rft.epage=2049&rft_id=info:doi/10.2169%2Finternalmedicine.53.2491&rft.externalDBID=n%2Fa&rft.externalDocID=10_2169_internalmedicine_53_2491 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-2918&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-2918&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-2918&client=summon |